You Searched For: (2S,3S)-2-Amino-3-methoxybutanoic acid
6 105 results were found
BRLSPIMMUNOSURF 170518 Imm SurfaceMatters
/m-be.vwr.com/fr_BE/images/BRLSPIMMUNOSURF_170518_Imm_SurfaceMatters.pdf
Thermo Scientific Immunoassay Plate Guide • Passive binding of biomacromolecules • Covalent coupling of smaller biomolecules • Capture of affinity-tagged biomolecules The right surface for your assay 2 Well configuration Advanced immunoassay surfa...
BRLSPIMMUNOSURF 170518 Imm SurfaceMatters
/m-ch.vwr.com/de_CH/images/BRLSPIMMUNOSURF_170518_Imm_SurfaceMatters.pdf
Thermo Scientific Immunoassay Plate Guide • Passive binding of biomacromolecules • Covalent coupling of smaller biomolecules • Capture of affinity-tagged biomolecules The right surface for your assay 2 Well configuration Advanced immunoassay surfa...
BRLSPIMMUNOSURF 170518 Imm SurfaceMatters
/m-fi.vwr.com/fi_FI/images/BRLSPIMMUNOSURF_170518_Imm_SurfaceMatters.pdf
Thermo Scientific Immunoassay Plate Guide • Passive binding of biomacromolecules • Covalent coupling of smaller biomolecules • Capture of affinity-tagged biomolecules The right surface for your assay 2 Well configuration Advanced immunoassay surfa...
BRLSPIMMUNOSURF 170518 Imm SurfaceMatters
/m-it.vwr.com/it_IT/images/BRLSPIMMUNOSURF_170518_Imm_SurfaceMatters.pdf
Thermo Scientific Immunoassay Plate Guide • Passive binding of biomacromolecules • Covalent coupling of smaller biomolecules • Capture of affinity-tagged biomolecules The right surface for your assay 2 Well configuration Advanced immunoassay surfa...
Upstream processing
/cms/bioprocessing_vaccines_upstream_processing
Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines, optimal production is achieved in mammal...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for mAbs
/cms/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/it/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Aurora Manufacturing Facility
/cms/aurora_manufacturing_facility
Aurora Manufacturing Facility Our 65000 sq. ft. manufacturing facility in Aurora OH USA includes a 12000 sq. ft. excipient processing center 3000 sq. ft. for repackaging 35000 sq. ft. warehouse 8000 sq. ft. office 8000 sq. ft. manufacturing area a...
Upstream processing for mAbs
/cms/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Upstream processing for mAbs
/cms/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Upstream processing for mAbs
/cms/it/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Aurora Manufacturing Facility
/cms/aurora_manufacturing_facility
Aurora Manufacturing Facility Our 65000 sq. ft. manufacturing facility in Aurora OH USA includes a 12000 sq. ft. excipient processing center 3000 sq. ft. for repackaging 35000 sq. ft. warehouse 8000 sq. ft. office 8000 sq. ft. manufacturing area a...
465 - 480 of 6 105